Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
FDA
, PMDA Feedback on
IgAN
Phase 3: Q3 2013
•
Completion of Bright
-
SC Enrollment: Q4 2013
scheduled for Q3 2013: FDA, PMDA Feedback on IgAN Phase 3, new target $8?!
the whole company is a mistery. never seen that a r/s was approved but not executed. do they try to get an extension from nasdaq or what else? nevertheless it seems that are making progress with their trials, hmm
june 18th was the day and I share opinion by randompretender and yours, but I don´t agree with his sentiment of silence, cause ANTH has corectly released personal changes in time ;o)
currently I can afford to lose what I´ve made at the big run july 12. I agree that it isn´t a good sign when someone from management leaves the company. on the other hand you also know there can also be a big return if they don´t fail with their trials. Sure it´s a risky game playing biotecstocks, look at todays CLSN for example, such high volatility, but also easy money
as I read correct in their corporate update by june, page 19, they wrote "FDA, PMDA Feedback on IgAN Phase 3: Q3 2013" so they should unveil some results then. nevertheless weak not to hear anything from their last events
indeed it´s really a joke here, especially todays tradingvolume. price reflects also the bad communication with their shareholders
maybe the CFO was forced to go, who knows? so anth cuts again its headcount, building shareholder value
it´s a normal boring trade day by anth, the usual all day volatility, so i´m not very disappointed. Still waiting for Madrid news, but also wether hopes nor expectations ;o) forgotten - good to have some other biotechs like xlsn
i´m strongly interested what they have to release from todays presentations in Madrid, could be well a catalyst
for sure not so soon, but as always I´m a little bit more optimistic than you
thanks. I´ve got written statement by IR dept that would match with your opinion of a possible extension
they have time until june 18 to regain nasdaq compliance with the minimum bid price. do they have any alternatives to r/s?
Alternatively, NASDAQ Marketplace Rule 4450(i) may permit the Company to transfer the common stock to the NASDAQ Capital Market if the common stock satisfies all criteria, other than compliance with the minimum bid price requirement, for initial inclusion on such market. In the event of such a transfer, the NASDAQ Marketplace Rules provide that the Company will be afforded an additional 180 calendar days to comply with the minimum bid price requirement while listed on the NASDAQ Capital Market.
nothing has changed since last six months here, whether their trials nor their financial situation, no substantially progress. nevertheless a good one for the future
further could be interesting the corporate update at the 2013 Annual Jefferies Global Healthcare Conference thursday next week and the two lecture sessions at the European League Against Rheumatism (EULAR) Annual European Congress of Rheumatology in Madrid, Spain june 13th. better than nothing ;o)
now it seems to be a little bit more
do you have already bought or still waiting?
CEO has bought again - great, good sign!
last time in january Husa climbed over .30 without any news so I must say I don´t care about any (technical) resistance
o yeah, people from the street having fear and drinking beer. I prefer Chateau Latour, vintage 1986, it´s similar to AAPL 1997 - the longer the better :o)
net income as of march 31 has been continually risen the last 4 years - so imagine this company weren´t run by these fools :o)
my understanding due to their clinical trials is an other then yours
don´t think so. only the VISTA-16 clinical study hab been halted in march 2012. but this has nothing to do with their current pipeline, especially with starting their phase III trial for disease lupus
http://files.shareholder.com/downloads/ABEA-3R5RJ7/2372054787x0x635140/A4EE5557-F704-4A50-B1E8-B8FECCADA5A6/Corporate_Update_February_2013_Web.pdf
let em sell
i´m asking myself again why institutional investors like midcap and lincoln park capital are putting money in anth even if they know that a r/s will take place. makes no sense for me
and we need a sec stop manipulating share price in general
last big selloff was in spring 2009 when the stock was at 2$ and it tripled in less than 3 months - so I´ve not much concerns, time will tell
should recover soon, especially when they are doing their business as usual again
great value here - what to do with so much easy earned money? ;o)
at the moment it seems to me that anthera is doing nothing to justify the deal especially share price they have done with mid cap (0.68) nor lincoln park capital (0.648). how dumb are these two partners or how smart is anthera?
news released today is dated at 5th april or am I wrong
nice news after the bell. maybe this and further announcements next will may help to avoid the r/s
first of all i´d like to see what they have to unveil in Brazil on April 20, so there should be a chance to recover the stock until shareholder meeting end of may
on the other hand would they anounce to release results even when they know this results arent positive?
interesting news on friday
a catalysator is needed, hopefully imminent
yep, next sell off at range .90 - 1$
for me insidercow show it all, buys and sells. this worthless stock has made 50 percent since december - and has lost most all of it gains, as I mentioned a week or so before. but as so often dean martin and his crew may help, please all enjoy ;o)
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=85010007
do you really think management has bought shares last december without any clue of any success? Institutional investors have also bought this february, maybe they have all timeframes like investors as mr buffet, so decades, not days